{"id":"W3203727420","doi":"10.1016/j.annonc.2021.08.2125","title":"LBA46 Efficacy and safety of poziotinib in treatment-naïve NSCLC harboring HER2 exon 20 mutations: A multinational phase II study (ZENITH20-4)","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Exon; Oncology; Multinational corporation; Internal medicine; Phases of clinical research; Phase (matter); Cancer research; Genetics; Gene; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00118803,0.001165656,0.001728063,0.0003652046,0.0004037218,0.001397443,0.0008718374,0.001034332,0.003172737],"category_scores_gemma":[0.0005507715,0.0005560717,0.001612798,0.0003925487,0.0008748944,0.0009133362,0.0003107171,0.003701002,0.001120671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001099066,"about_ca_system_score_gemma":0.001281554,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001993724,"about_ca_topic_score_gemma":0.005111585,"domain_scores_codex":[0.9996427,0.0001430317,0.00001424309,0.00005352951,0.00004032182,0.0001061807],"domain_scores_gemma":[0.9996568,0.00005127137,0.00007827247,0.00003726427,0.00002058223,0.0001557865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5358722,0.05221221,0.01661833,0.00103251,0.003609215,0.0004174433,0.0004368706,0.00607337,0.1685833,0.0005757965,0.01031403,0.2042547],"study_design_scores_gemma":[0.3920338,0.4943231,0.07462032,0.00007785423,0.002164924,0.001303533,0.0001961875,0.003794575,0.02298782,0.0003763778,0.00800235,0.0001189976],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944522,0.002035884,0.0002590135,0.0003416879,0.00006728375,0.0003120833,0.0009066228,0.0001265373,0.001498568],"genre_scores_gemma":[0.9909061,0.00206262,0.0006817802,0.0004439937,0.00009702409,0.0003722438,0.002449885,0.00005452839,0.002931817],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003172737,"threshold_uncertainty_score":0.0106138,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07694720565537184,"score_gpt":0.4702431148677343,"score_spread":0.3932959092123625,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}